In this well-characterized cohort of patients with relatively advanced HFpEF, 57% of patients had high circulating CRP levels, and elevated CRP was associated with younger age, obesity, a diagnosis of COPD, decreased peak oxygen consumption and greater neurohumoral activation (aldosterone and endothelin-1). Here, CRP is linked to obesity disorder.